asacol
chiesi new zealand limited t/a emerge health - mesalazine 16.67%{relative} - suppository - 16.67% w/w - active: mesalazine 16.67%{relative} excipient: hard fat
asacol 400
tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 400 mg - mesalazine - mesalazine - ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes.
asacolon 1600 mg modified-release tablets
tillotts pharma gmbh - mesalazine - modified-release tablet - 1600 milligram(s) - aminosalicylic acid and similar agents; mesalazine
asacolon 1600 mg modified-release tablets
tillotts pharma gmbh warmbacher strasse 80, 79618 rheinfelden, germany - mesalazine - modified-release tablet - mesalazine 1600 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents
asacolon 1000 mg suppository
tillotts pharma gmbh - mesalazine - suppository - 1000 milligram(s) - mesalazine
asacol 800
tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 800 mg - mesalazine - mesalazine - ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes.
asacolon 400 milligram tablets gastro-resistant
tillotts pharma limited - mesalazine - tablets gastro-resistant - 400 milligram
asacolon 800 milligram tablets gastro-resistant
tillotts pharma limited - mesalazine - tablets gastro-resistant - 800 milligram
asacolon 500 milligram suppositories
tillotts pharma limited - mesalazine - suppositories - 500 milligram
casacol expectorant syrupmethoxyphenamine hydrochloride 20 mg/5 ml guaiphenesin 100 mg/5 ml sodium citrate 200 mg/5 ml
phoenix labs - methoxyphenamine hydrochloride; sodium citrate; guaiphenesin - syrup - 20 mg/5ml/100 mg/5ml/200 mg/5ml - expectorants; combinations